Written May 30, 2025 | David Brown. Posted in Stratcann
Canada was again the largest exporter of medical cannabis products to Germany as of the first quarter of 2025.
Of the 37,223 kilograms of dried cannabis flower imported into Germany in the first three months of 2025, about half, 16,057 kg, were from Canada. The second-largest importing country into Germany was Portugal, with 12,059 kg, and Denmark in a distant third, with 2,634 kg, out of 16 importing countries.
Cannabis flower imports into Germany have increased over the last five quarters from just 8,143 kg in Q1 2024. The amount of cannabis imported from Canada in the first three months of 2025 was about half of the total amount (33,155 kg) imported from Canada in all of 2024. That figure doubled from the 16,895 kg imported from Canada in 2023.
The import of cannabis for medical or medical-scientific purposes into Germany is expected to continue, provided that a corresponding permit is obtained under Section 4 of the Medical Cannabis Act (MedCanG).
Cannabis for medical purposes that was cultivated in Germany under state control can also be exported, although Canada has continued to only allow cannabis imports for scientific purposes, rather than for medical use.
An increasing number of Canadian cannabis companies have been turning to the international export market, drawn by higher prices and higher demand, especially in countries like Australia, Germany, Israel, and the UK. Some cannabis producers in Israel, Colombia, and Australia have expressed concern about their ability to compete with the amount of imports coming from countries like Canada.
From October 2018 to September 2024 (most recently available data), there were 295,933,850 grams of cannabis and 52,662.1 litres of cannabis oil exported from Canada to markets like Australia, Israel, Germany, and the UK.
Based in the US and Canada, Tilray received the first cannabis cultivation licence issued under Germany’s new Cannabis Act in July. This licence allows Aphria RX to cultivate and manufacture cannabis for medical purposes in Germany.
The American cannabis company, which operates in Canada, the United States, Europe, Australia, and Latin America, was the first to receive a cannabis production licence in the country. Canadian cannabis company Aurora and the German company Demecan are also now licensed for production in the country, as well.
In February 2024, Germany passed the German Medical Cannabis Act, expanding the country’s medical cannabis laws.